Carbidopa, entacapone, levodopa (Stalevo)
Carbidopa, entacapone, levodopa
Equity Pharmaceutical (Pty) Ltd
Registration
- Applicant
- Equity Pharmaceutical (Pty) Ltd
- Certificate holder
- Equity Pharmaceuticals (Pty) Ltd
- Registrations
- 3
- Schedule source
- Consolidated Schedules 06 July 2026
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Stalevo 50/12,5 EACH TABLET CONTAINS CARBIDOPA 12,5 mg ENTACAPONE 200,0 mg LEVODOPA 50,0 mg | 50/12,5Tablet | 38006738/5.4.1/0067Approved 28 February 2021 | Registered | S4 | PIPIL |
| Stalevo 150/37,5 EACH TABLET CONTAINS CARBIDOPA 37,5 mg ENTACAPONE 200,0 mg LEVODOPA 150,0 mg | 150/37,5Tablet | 38013738/5.4.1/0137Approved 28 February 2021 | Registered | S4 | PIPIL |
| Stalevo 100/25 EACH TABLET CONTAINS CARBIDOPA 27,0 mg ENTACAPONE 200,0 mg LEVODOPA 100,0 mg | 100/25Tablet | 38013838/5.4.1/0138Approved 28 February 2021 | Registered | S4 | PIPIL |
Regulatory status
Where S4 sits on the scale
Prescription-only medicine.
Schedule 4 covers most ordinary prescription medicines. You need a prescription from an authorised prescriber, such as a doctor or dentist, and a pharmacist dispenses it. Its price, name, pack size and strength can still be told to the public, as long as nothing links it to what it treats.
Schedule S4, matched to the Consolidated Schedules by ingredient, confidence medium.
Who may supply: A pharmacist dispensing against a written or verbal prescription from an authorised prescriber; a veterinarian, who may also prescribe, compound or dispense it directly; a medical practitioner or dentist, who may prescribe it and may compound or dispense it directly only if licensed under section 22C(1)(a); manufacturers and wholesalers may supply people who may lawfully possess it; and, for animal treatment, a person practising a para-veterinary profession, on a veterinarian's written or verbal instruction.
Consolidated Schedules listings for Carbidopa, entacapone, levodopa
S4: Carbidopa
Consolidated Schedules 06 July 2026, line 5661
S4: Entacapone
Consolidated Schedules 06 July 2026, line 6193
S4: Levodopa
Consolidated Schedules 06 July 2026, line 6907
Pharmacological class: Anti-Parkinsonism preparations. (class 5.4.1)
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
Combination product
This product contains more than one active ingredient, so it has no single molecular structure.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.